Workflow
Growth Stock
icon
Search documents
The Most Intelligent Growth Stock to Buy With $2,000 Today
The Motley Fool· 2025-05-03 08:31
Company Overview - Remitly Global is a remittance provider with a market cap of $4.1 billion, experiencing significant growth and market share gains [2][4]. - The company has 7.8 million active customers as of Q4 2024, reflecting a year-over-year growth of 32% [3]. Market Position - Remitly is gaining customers from Western Union due to lower fees and user-friendly services, targeting key immigrant groups in the U.S. [4]. - The company currently holds approximately 3% market share in the remittance sector, processing $15.4 billion in volume in Q4 of the previous year [4]. Growth Potential - The remittance market is expanding, providing Remitly with a dual advantage of market share growth and sector growth, leading to a cumulative revenue increase of 130% over the last three years [6]. - Revenue growth is expected to continue, with projections indicating that Remitly could achieve over $3 billion in annual sales within five years [11]. Profitability and Financials - Remitly's gross margin is approaching 60%, despite posting a slight operating loss last year due to high spending on marketing and technology [7][8]. - The company is expected to reach operating leverage as it scales, with potential profit margins approaching 20% in the next five years [9]. Investment Appeal - The current market cap undervalues Remitly's profit potential, with a projected P/E ratio dropping below 10 if revenue growth continues [12]. - Investing $2,000 today could yield 100 shares of a fast-growing company at a reasonable price compared to other high-growth stocks [2][12].
Is Tesla Stock the Smartest Investment You Can Make Today?
The Motley Fool· 2025-05-02 10:10
Tesla's (TSLA -0.48%) stock is undoubtedly risky, but then again, so are many other stocks on the market, and there's no such thing as a reward without risk. The question is whether the risk/reward calculation makes sense for Tesla stock. Here's one view on matters.Tesla looks and walks like a growth stockIt's easy to point at the stock's current valuation based on earnings, cash flow, and sales and quickly conclude that the stock is ridiculously overvalued. For example, here's a look at Tesla's enterprise ...
2 Growth Stocks Down 45% or More to Buy in May
The Motley Fool· 2025-05-01 08:25
Investing in growth stocks can help you build tremendous wealth for retirement. Many top growth stocks have fallen this year as Wall Street worries about a recession. For an investor focused on the long term, this can work to your advantage by being able to invest in strong companies at lower valuations.There are some up-and-coming restaurant and apparel brands that are still in the early innings of their long-term growth to consider buying right now. Here are two trading well off their highs that should ma ...
Progressive (PGR) is an Incredible Growth Stock: 3 Reasons Why
ZACKS· 2025-04-30 17:45
Core Viewpoint - Growth investors seek stocks with above-average financial growth, but identifying such stocks can be challenging due to inherent risks and volatility [1] Group 1: Growth Stock Identification - The Zacks Growth Style Score system helps identify promising growth stocks by analyzing real growth prospects beyond traditional metrics [2] - Progressive (PGR) is highlighted as a recommended stock with a favorable Growth Score and a top Zacks Rank [2] Group 2: Earnings Growth - Earnings growth is crucial for investors, with double-digit growth indicating strong prospects [3] - Progressive's historical EPS growth rate is 14.2%, with a projected EPS growth of 11.8% this year, significantly higher than the industry average of 1.4% [4] Group 3: Cash Flow Growth - High cash flow growth is essential for growth-oriented companies, allowing them to fund new projects without external financing [5] - Progressive's year-over-year cash flow growth is 115.9%, far exceeding the industry average of 15.6% [5] - The company's annualized cash flow growth rate over the past 3-5 years is 14.8%, compared to the industry average of 11.6% [6] Group 4: Earnings Estimate Revisions - Positive trends in earnings estimate revisions correlate strongly with near-term stock price movements [7] - Current-year earnings estimates for Progressive have been revised upward, with a 2.4% increase in the Zacks Consensus Estimate over the past month [8] Group 5: Overall Assessment - Progressive has achieved a Growth Score of B and a Zacks Rank 2 due to positive earnings estimate revisions, indicating potential outperformance and suitability for growth investors [10]
Looking for a Growth Stock? 3 Reasons Why CACI International (CACI) is a Solid Choice
ZACKS· 2025-04-29 17:45
Core Viewpoint - Investors are increasingly seeking growth stocks that demonstrate above-average growth potential, but identifying such stocks can be challenging due to inherent risks and volatility [1] Group 1: CACI International Overview - CACI International is highlighted as a recommended growth stock based on its favorable Growth Score and top Zacks Rank [2] - The company has a historical EPS growth rate of 9.8%, with projected EPS growth of 14.3% this year, significantly outperforming the industry average of 3% [4] Group 2: Financial Metrics - CACI International's year-over-year cash flow growth stands at 5.9%, exceeding the industry average of 4.9% [5] - The company's annualized cash flow growth rate over the past 3-5 years is 11.8%, compared to the industry average of 6.1% [6] Group 3: Earnings Estimate Revisions - There have been upward revisions in current-year earnings estimates for CACI International, with the Zacks Consensus Estimate increasing by 0.6% over the past month [8] - The positive trend in earnings estimate revisions correlates strongly with near-term stock price movements, indicating potential for growth [7] Group 4: Investment Potential - CACI International holds a Zacks Rank of 2 (Buy) and a Growth Score of B, suggesting it is a solid choice for growth investors [10]
Celsius Stock Is Trading Below $40: Should You Buy It Hand Over Fist Right Now and Hold for 20 Years?
The Motley Fool· 2025-04-29 17:15
Celsius (CELH -3.09%) was once the talk of the town among investors. In the five-year period leading up to the stock's Mar. 2024 all-time high, it surged more than 7,300%. The business was putting up ridiculous growth numbers year after year.However, the remainder of 2024 was a rude awakening as sales started to come under pressure. The beverage stock is 64% off its peak, as of this writing, despite climbing 44% in the past three months. Clearly, volatility is still a major part of the story.Celsius is trad ...
Xylem: An Undervalued Stock With Secular Tailwinds
Seeking Alpha· 2025-04-29 08:10
Core Insights - The article discusses the journey to financial independence through disciplined living and strategic investing, highlighting the importance of dividend growth investing and identifying undervalued high-quality stocks [2]. Group 1: Financial Independence Journey - The individual transitioned from a state of financial struggle at age 27 to achieving financial freedom by age 33 [2]. - The approach involved living well below means and making intelligent investment decisions with hard-earned capital [2]. Group 2: Investment Focus - The content emphasizes dividend growth investing as a primary strategy, focusing on living off dividends and seeking high-yield investment opportunities [2]. - There is a particular interest in identifying undervalued high-quality dividend growth stocks for long-term investment [2].
Stantec (STN) is an Incredible Growth Stock: 3 Reasons Why
ZACKS· 2025-04-28 17:45
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to find a great growth stock.That's because, these stocks usually carry above-average risk and volatility. In fact, betting on a stock for which the growth story is actually over or nearing its end could lead to significant loss.However, the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks ...
Emcor Group: Long-Term Beneficiary Of AI Growth
Seeking Alpha· 2025-04-27 19:39
Core Insights - The article emphasizes the importance of investing in growth and momentum stocks that are reasonably priced and have the potential to outperform the market over the long term [1] - It highlights David's successful investment strategy, which involved advising investors to buy at the bottom of the financial crisis in March 2009, leading to significant market gains [1] Investment Strategy - David focuses on high-quality growth stocks and employs options as part of his investment strategy [1] - The S&P 500 saw an increase of 367% and the Nasdaq increased by 685% from 2009 to 2019, showcasing the effectiveness of his investment approach [1] Investor Guidance - The article aims to assist investors in making money through strategic investments in quality stocks [1]
野村:医疗保健板块-1-3月业绩关注要点 - 预计关税基本无影响,关注防御性成长股
野村· 2025-04-27 03:56
Investment Rating - The report assigns a "Buy" rating to several companies including Ain Holdings, Tsumura, Sawai Group Holdings, Litalico, M3, JMDC, Medley, Gakken Holdings, Ship Healthcare Holdings, SMS, and Cyberdyne, while others are rated "Neutral" [29][29][29]. Core Insights - The healthcare sector is expected to show resilience against US tariffs, with a focus on defensive growth stocks that can benefit from system risks and return to growth trajectories [1][2]. - The report emphasizes the importance of stock selection based on defensive characteristics, earnings recovery potential, and contributions to the medical DX market [1][2]. - There is an anticipated recovery in earnings for companies affected by previous revisions to medical reimbursements and COVID-related subsidies, paving the way for a return to normal growth [2][3]. Summary by Relevant Sections Defensive Growth Stocks - Companies like Ain Holdings are expected to benefit from reduced reimbursement impacts and improved business efficiency through dispensing DX [1][1]. - Tsumura is projected to see growth from higher domestic sales volumes and overseas expansion due to deregulation in China [1][1]. - Sawai Group Holdings is anticipated to grow sales and improve margins by providing a stable supply of generics [1][1]. Earnings Recovery - Litalico is expected to return to profitability as disruptions from curriculum changes in the child welfare segment ease [1][1]. - M3 is forecasted to benefit from improved pharmaceutical marketing operations and increased uptake of medical institution DX [1][1]. - JMDC is expected to see higher unit prices and more projects leveraging its competitive advantages [1][1]. Growth Trajectory - Companies like Medley are expected to recover in their HR platform business and see growth in their medical platform business [1][1]. - Ship Healthcare Holdings anticipates steady demand for hospital remodeling projects and growth driven by renewed demand for replacement medical equipment [20][20]. - Cyberdyne is focusing on establishing cybernics centers in Southeast Asia and benefiting from government approvals in Japan [28][28].